4th Quarter - Report
GREENWICH BIOSCIENCES, INC. for GREENWICH BIOSCIENCES, INC.
Client
Income
—
Expenses
$220,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY2021 Approps (Provisions related to patient safety, product regulations, and FDA enforcement)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN WALTER | — |
Health Issues HCR
FDA guidance on CBD enforcement discretion
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN WALTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.